Evogene Ltd.EVGN

Market cap
P/E ratio
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Loss-21-21-19-26-30-30-26-18
Depreciation22221222
Amortization of intangible assets--011111
Share-based compensation22243122
Remeasurement of Convertible SAFE-----000
Pre-funded warrants issuance expenses---0----
Net financing income--2-11-311
Loss (gain) from sale of property, plant and equipment---0--0-0-1
Excess of initial fair value of pre-funded warrants over transaction proceeds--------3
Amortization of deferred expenses related to issuance of warrants-------0
Remeasurement of pre-funded warrants and warrants--------7
Share of loss of an associate--------0
Taxes on income (tax benefit)000000-00
Adjustments to the profit or loss items34284741
Increase in trade receivables0-00-0-0-0-0-1
Decrease (increase) in other receivables00-1-111-11
Decrease (increase) in inventories-----0-00-2
Adjustments for deferred tax expense------00-
Increase in long term deposits-0--0--0---
Increase (decrease) in trade payables-0-0-0-01-01-1
Increase (decrease) in employees and payroll accruals0--000-11-1
Increase (decrease) in other payables000-000-10
Decrease in deferred revenues and other advances----0-0-0-1
Changes in asset and liability-0-0-1-12-1-0-3
Interest received21100011
Interest paid--000000
Taxes paid00000000
Net cash used in operating activities-16-15-18-20-25-24-22-20
Purchase of property, plant and equipment10111111
Proceeds from sale of marketable securities23642724127-
Purchase of marketable securities12322-2311-
Proceeds from sale of property, plant and equipment------00
Proceeds from short-term bank deposits-------27
Investment in short-term bank deposits-------17
Net cash provided by (used in) investing activities1517379-2113-510
Issuance of a subsidiary's preferred shares to non-controlling interests------10-
Proceeds from issuance of ordinary shares, pre-funded warrants and warrants-------6
Proceeds from issue of ordinary shares---1930080
Proceeds from issuance of Convertible SAFE-----10--
Proceeds from exercise of options10-000--
Repayment of lease liabilities--111111
Proceeds from government grants00001010
Repayment of government grants00100000
Net cash provided by financing activities10920309185
Exchange rate differences on cash and cash equivalent balances0-0011-2-0-0
Decrease in cash and cash equivalents022911-14-3-8-5
Purchase of property, plant and equipment00000000
Increase Of Operating Lease Rightofuseassets--3-01002
Exercise of options---0----
Acquisition of intangible assets--17-----
Exercise of pre-funded warrants----4--2
Investment in affiliated company with corresponding deferred revenues-------0